Johnson & Johnson | NYSE:JNJ - Fraywire Market Portal
⚡ Login to use Pulse AI
Simple Chart
Advanced Chart
Login for Volatility Chart


Johnson & Johnson on Glideslope

News aggregated by Glideslope.ai
October 16, 2025
More than 3,000 U.K. claimants accuse U.S. pharmaceutical giant Johnson & Johnson of knowingly selling asbestos-tainted talcum powder, making them...
featured image
October 16, 2025
More than 3,000 people in Britain have joined a lawsuit accusing the company of knowing that its baby powder contained carcinogenic fibers, including ...
October 16, 2025
The claim involves 3,000 people and focuses on internal memos and scientific reports, seen by the BBC.
October 14, 2025
Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes.
featured image
October 8, 2025
A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the c...
featured image
October 7, 2025
A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liab...
featured image
October 7, 2025
The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc powder products were t...
featured image
September 22, 2025
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven ...
September 10, 2025
(RTTNews) - Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration has approved INLEXZO (gemcitabine intravesical s...
featured image
September 6, 2025
Explore the exciting world of Johnson & Johnson (NYSE: JNJ) with our contributing expert analysts in this Motley Fool Scoreboard epis...